← Open Payments lookup

FELIPE GALVAN: Open Payments

NPI 1841327459 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,444 in 297 payments from 24 companies in 2025. Trend: 2023 $4,553 · 2024 $6,142 · 2025 $6,444

Food & beverage: $6,098Education: $346
CompanyPaymentsAmount
UCB, Inc.25$854
Janssen Biotech, Inc.49$834
ABBVIE INC.42$754
Galderma Laboratories, L.P.29$671
Incyte Corporation22$465
GENZYME CORPORATION16$409
Arcutis Biotherapeutics, Inc.13$302
Ortho Dermatologics, a division of Bausch Health US, LLC13$274
Janssen Scientific Affairs, LLC3$245
Amgen Inc.13$242

Products named: TREMFYA, Bimzelx, RINVOQ, NEMLUVIO, DUPIXENT, OPZELURA, OTEZLA, Sotyktu.

Industry payments across TX — which companies pay providers there.